FIGURE

Fig. 1

ID
ZDB-FIG-180327-1
Publication
Melong et al., 2017 - Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
Other Figures
All Figure Page
Back to All Figure Page
Fig. 1

Xenografted LNCaP cells proliferate significantly in vivo with the addition of testosterone. (A) Schematic of in vivo zebrafish XT microinjection and cell proliferation assay. (B) Representative brightfield and fluorescent images of casper embryos injected with CMTMR labeled LNCaP cells at 24 hpi (baseline) and 96 hpi (endpoint) without and with the addition of testosterone. Scale bar = 200 microns. (C) Quantification of XT LNCaP cell engraftment and fold change ex vivo without and with the addition of 125 nM testosterone (T). LNCaP cells engrafted and proliferated in the XT model indicated by the significant increase in the fold change from baseline numbers (24 hpi) to the endpoint (96 hpi), which increased even more with the addition of testosterone. Error Bars = Mean ± SEM (N = 4); *P < 0.05, **P < 0.01 for significant increase in number of cells determined using the Student’s t-test. Groups of 20 embryos were sacrificed per replicate.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Sci. Rep.